A call for the development and implementation of a targeted national melanoma screening program

Archives of Dermatology

Volumn 142, Issue 4, 2006, Pages 504-507

  Geller, Alan C ^a   Miller, Donald R ^b   Swetter, Susan M ^b   Demierre, Marie France ^b   Gilchrest, Barbara A ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH MAINTENANCE ORGANIZATION; HEALTH PROGRAM; HUMAN; LAW; MELANOMA; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCREENING; SKIN EXAMINATION; HEALTH CARE PLANNING; LEGAL ASPECT; MASS SCREENING; METHODOLOGY; PROGRAM DEVELOPMENT; PUBLIC HEALTH; SKIN TUMOR; UNITED STATES;

HEALTH PLAN IMPLEMENTATION; HUMANS; MASS SCREENING; MELANOMA; NATIONAL HEALTH PROGRAMS; PATIENT EDUCATION; PROGRAM DEVELOPMENT; SKIN NEOPLASMS; UNITED STATES;

EID: 33646119413     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.4.504     Document Type: Editorial

References (29)

1. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
2. Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969-1999. JAMA. 2002;288:1719-1720.
3. Koh HK. Cutaneous melanoma. N Engl J Med. 1991;325:171-182.
4. US Preventive Services Task Force. Recommendations and rationale for screening for skin cancer. Am J Prev Med. 2001;20(3)(suppl):44-46.
5. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2002. National Cancer Institute Web site. Available at: http://seer.cancer.gov/csr/1975_2002/. Accessed December 1, 2005.
6. American Cancer Society. Cancer Facts and Figures. Atlanta, Ga: American Cancer Society; 2005.
7. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996;3:47-53.
8. Geller AC, Sober AJ, Zhang Z, et al. Strategies for improving melanoma education and screening for men age ≥50 years: findings from the American Academy of Dermatological National Skin Cancer Screening Program. Cancer. 2002;95:1554-1561.
9. Massachusetts Health Quality Partners Web site. MHQP home page. Available at: http://mhqp.org/default.asp?nav=010000. Accessed December 1, 2005.
10. Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK. Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol. 1999;41:738-745.
11. Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC Jr, Sober AJ. Risk factors for cutaneous melanoma: a practical method of recognizing predisposed individuals. JAMA. 1987;258:3146-3154.
12. Mikkilineni R, Weinstock MA, Goldstein MG, Dube CE, Rossi JS. The impact of the basic skin cancer triage curriculum on providers' skills, confidence, and knowledge in skin cancer control. Prev Med. 2002;34:144-152.
13. Ford D, Bliss JM, Swerdlow AJ, et al; International Melanoma Analysis Group (IMAGE). Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer. 1995;62:377-381.
14. Halpern AC, Guerry D IV, Elder DE, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma: a case-control study. Arch Dermatol. 1991;127:995-999.
15. Weinstock MA, Goldstein MG, Dube CE, Rhodes AR, Sober AJ. Basic skin cancer triage for teaching melanoma detection. J Am Acad Dermatol. 1996;34:1063-1066.
16. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292:2771-2776.
17. Robinson JK, Turrisi R. Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch Dermatol. 2006;142:447-452.
18. Weinstock MA, Nguyen FQ, Risica PM. Patient and referring provider satisfaction with teledermatology. J Am Acad Dermatol. 2002;47:68-72.
19. Piper ME, Fiore MC, Smith SS, et al. Use of the vital sign stamp as a systematic screening tool to promote smoking cessation. Mayo Clin Proc. 2003;78:716-722.
20. Koh HK, Geller AC, Miller DR, Davis BE, Lew RA. Skin cancer: prevention and control. In: Greenwald P, Kramer BS, Weed DL, eds. Cancer Prevention and Control. New York, NY: Marcel Dekker Inc; 1995.
21. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol. 2005;125:685-691.
22. Geller AC. Milestones in public education. Skin Cancer Found. 2003;21:41-44.
23. The National Breast and Cervical Cancer Early Detection Program-Reducing Mortality Through Screening resource page. Centers for Disease ControlWebsite. Available at: www.cdc.gov/cancer/nbccedp/about.htm. Accessed December 1, 2005.
24. Cassileth BR, Clark WH Jr, Lusk EJ, et al. How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol. 1986;14:555-560.
25. Federman D, Hogan D, Taylor FR, et al. A comparison of diagnosis, evaluation, and treatment of patients with dermatologic disorders. J Am Acad Dermatol. 1995;32:726-729.
26. Wagner RF Jr, Wagner D, Tomich JM, Wagner KD, Grande DJ. Diagnoses of skin disease: dermatologists vs nondermatologists. J Dermatol Surg Oncol. 1985;11:476-479.
27. Manson JE, Rexrode KM, Garland FC, Garland CF, Weinstock MA. The case for a comprehensive national campaign to prevent melanoma and associated mortality. Epidemiology. 2000;11:728-734.
28. Moore MM, Geller AC, Zhang Z, et al. Skin cancer examination teaching in US medical education. Arch Dermatol. 2006;142:439-444.
29. And then there were none: the coming physician supply problem. California Medical Association Web site. Available at: http://www.cmanet.org/publicdoc.cfm/574/1#4. Accessed December 1, 2005.